NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT02703571 2020-12-21Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsNovartisPhase 1 Terminated95 enrolled